The Sema4D expression in BMMCs was examined in B-ALL patients who had received chemotherapy, and the PBMCs were not collected during the chemotherapy for the ethical consideration. The gene discussed is SEMA4D; the disease is precursor B-cell acute lymphoblastic leukemia.